Ultrasound Assessment of BC in the NICU
Use of Bedside Ultrasound to Assess Neonatal Body Composition in the Neonatal Intensive Care Unit
1 other identifier
observational
68
1 country
1
Brief Summary
The overall objective of the proposal is to evaluate the ability of ultrasound to predict and routinely (weekly) monitor changes in the body composition of healthy preterm infants in the neonatal intensive care unit (NICU) in response to nutritional intake. The investigators hypothesize that ultrasound is an accurate method to routinely monitor the quality of weight gain and assess the adequacy of nutritional provision for premature infants in the neonatal intensive care unit. The investigators will address the hypothesis in the following Specific Aims: Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat free mass in healthy, premature infants. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP). Stable isotope dilution techniques will be used in a subset of our population as a secondary source of validation. Specific Aim 2: Determine whether ultrasound measurements can detect clinically relevant (weekly) changes in body composition in healthy premature infants. Ultrasound will be used to obtain serial (weekly) measurements of muscle and adipose tissue thickness (triceps, abdomen, quadriceps) until discharge in healthy, premature infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2017
CompletedFirst Posted
Study publicly available on registry
August 7, 2017
CompletedStudy Start
First participant enrolled
October 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
ExpectedJanuary 8, 2026
January 1, 2026
4.3 years
July 28, 2017
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Whole-body measurements of body composition
Measurement of whole body fat mass and fat-free mass via air displacement plethysmography and stable isotope dilution.
Up to 6 weeks
Interventions
validation of portable ultrasound to measure body composition
Eligibility Criteria
Infants admitted to the University of Minnesota NICU under the care of the PI and/or her colleagues.
You may qualify if:
- Healthy, premature infants 25-34+6 weeks gestational age at birth
- Admitted to the University of Minnesota Masonic Children's Hospital NICU
- Stable on room air or can be removed from respiratory support for 5 minutes
- Written or verbal (telephone) informed consent can be secured from a parent within 1 week of admission to the NICU
You may not qualify if:
- Require medical support preventing ADP measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Ramel, MD
University of Minnesota Department of Pediatrics
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2017
First Posted
August 7, 2017
Study Start
October 23, 2017
Primary Completion
January 31, 2022
Study Completion (Estimated)
December 31, 2027
Last Updated
January 8, 2026
Record last verified: 2026-01